BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33247227)

  • 1. SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.
    Vukadin L; Kim JH; Park EY; Stone JK; Ungerleider N; Baddoo MC; Kong HK; Richard A; Tran J; Giannini H; Flemington EK; Lim SS; Ahn EE
    Cancer Gene Ther; 2021 Sep; 28(9):1000-1015. PubMed ID: 33247227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.
    Kuvardina ON; Herglotz J; Kolodziej S; Kohrs N; Herkt S; Wojcik B; Oellerich T; Corso J; Behrens K; Kumar A; Hussong H; Urlaub H; Koch J; Serve H; Bonig H; Stocking C; Rieger MA; Lausen J
    Blood; 2015 Jun; 125(23):3570-9. PubMed ID: 25911237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.
    Edwards H; Xie C; LaFiura KM; Dombkowski AA; Buck SA; Boerner JL; Taub JW; Matherly LH; Ge Y
    Blood; 2009 Sep; 114(13):2744-52. PubMed ID: 19638627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
    Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
    Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
    Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.
    Xu G; Kanezaki R; Toki T; Watanabe S; Takahashi Y; Terui K; Kitabayashi I; Ito E
    Leukemia; 2006 Jun; 20(6):1002-8. PubMed ID: 16628190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis.
    Alejo-Valle O; Weigert K; Bhayadia R; Ng M; Issa H; Beyer C; Emmrich S; Schuschel K; Ihling C; Sinz A; Zimmermann M; Wickenhauser C; Flasinski M; Regenyi E; Labuhn M; Reinhardt D; Yaspo ML; Heckl D; Klusmann JH
    Blood; 2022 Feb; 139(5):651-665. PubMed ID: 34570885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
    Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
    PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proto-oncogene ERG in megakaryoblastic leukemias.
    Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
    Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
    Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
    Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis].
    Wang SJ; Wang CQ; Hu XT; Yu XR; Fu CL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):499-505. PubMed ID: 35968594
    [No Abstract]   [Full Text] [Related]  

  • 12. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
    Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
    Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
    Ajore R; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
    Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
    Ge Y; LaFiura KM; Dombkowski AA; Chen Q; Payton SG; Buck SA; Salagrama S; Diakiw AE; Matherly LH; Taub JW
    Leukemia; 2008 Mar; 22(3):521-9. PubMed ID: 18094719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistant gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement during megakaryocytic differentiation.
    Sato T; Ota S; Kakuda H; Miura N; Niimi H; Ito M; Asai T; Tsuruo T; Fuse A
    Leuk Lymphoma; 1995 Aug; 18(5-6):515-20. PubMed ID: 8528062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic Leukemia.
    Klairmont MM; Hoskoppal D; Yadak N; Choi JK
    Am J Clin Pathol; 2018 Oct; 150(5):461-467. PubMed ID: 30052718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.